Literature DB >> 27236379

Clinical outcomes of duodenal switch with a 200-cm common channel: a matched, controlled trial.

Stéfane Lebel1, Geneviève Dion2, Simon Marceau2, Simon Biron2, Maud Robert2, Laurent Biertho2.   

Abstract

BACKGROUND: Biliopancreatic diversion with duodenal switch (BPD-DS) with a 100-cm common channel has been our treatment of choice for morbid obesity since the early 1990s. This procedure offers excellent long-term weight loss but can be associated with significant side effects.
OBJECTIVES: To assess the effect on clinical and nutritional parameters of increasing the common channel to 200 cm. SETTINGS: University-affiliated tertiary care center.
METHODS: Patients who underwent a BPD-DS with a 200-cm common channel (study group, n = 36) were matched 1:1 for age, sex, body mass index (BMI), and main co-morbidities with patients who underwent a BPD-DS with a 100-cm common channel (control group). The strict alimentary limb was 150 cm in both groups.
RESULTS: The mean age was 55±9 versus 53±7 years (P = .3), with 50% women and a BMI of 49±8 kg/m(2) versus 50±6 kg/m(2) (P = .9). Follow-up rate was 97%, with a minimum follow-up of 3 years. There were no significant differences in the remission rate of major co-morbidities between the 2 groups. At 3 years, the excess weight loss was 61±22% versus 68±18% (P = .18) and the total weight loss was 33±11% versus 38±9% (P = .055) in the study group versus control group, respectively. The study group had a lower incidence of severe protein deficiency (11% versus 19%, P = .3) and hyperparathyroidism (17.1% versus 35.3%, P = .17); required a lower amount of vitamins A and D (P<.05); and had a decreased number of daily bowel movements (2.0 versus 2.9, P = .03).
CONCLUSION: In this population, BPD-DS with a 200-cm common channel offered similar remission rate of co-morbidities compared with standard BPD-DS. It was associated with similar weight loss at nadir, followed by a more significant weight regain. It might yield a lower rate of nutritional complications. Long-term randomized data are needed to detect other potential advantages.
Copyright © 2016 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bariatric surgery; Biliopancreatic diversion; Duodenal switch; Metabolic surgery

Mesh:

Substances:

Year:  2016        PMID: 27236379     DOI: 10.1016/j.soard.2016.01.014

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  11 in total

1.  A Prospective Randomized Controlled Trial of the Metabolic Effects of Sleeve Gastrectomy with Transit Bipartition.

Authors:  Fernanda R Azevedo; Sergio Santoro; Maria L Correa-Giannella; Marcos T Toyoshima; Daniel Giannella-Neto; Daniela Calderaro; Danielle M Gualandro; Pai C Yu; Bruno Caramelli
Journal:  Obes Surg       Date:  2018-10       Impact factor: 4.129

2.  Technical Options for Malabsorption Issues After Single Anastomosis Duodenoileal Bypass with Sleeve Gastrectomy.

Authors:  Ramon Vilallonga; José Maria Balibrea; Anna Curell; Oscar Gonzalez; Enric Caubet; Andrea Ciudin; Angel Michael Ortiz-Zúñiga; José Manuel Fort
Journal:  Obes Surg       Date:  2017-12       Impact factor: 4.129

3.  How to Switch to the Switch: Implementation of Biliopancreatic Diversion with Duodenal Switch into Practice.

Authors:  Hamzeh M Halawani; Gintaras Antanavicius; Fernando Bonanni
Journal:  Obes Surg       Date:  2017-09       Impact factor: 4.129

4.  Robotic-Assisted Laparoscopic Biliopancreatic Diversion, Vertical Sleeve Gastrectomy with Traditional Roux-en-Y Duodenal Switch.

Authors:  Muhammad A Jawad; Lars Nelson; Rena C Moon; Andre F Teixeira
Journal:  Obes Surg       Date:  2017-01       Impact factor: 4.129

Review 5.  Single Anastomosis Duodeno-Ileal Switch (SADIS): A Systematic Review of Efficacy and Safety.

Authors:  Saeed Shoar; Lauren Poliakin; Rebecca Rubenstein; Alan A Saber
Journal:  Obes Surg       Date:  2018-01       Impact factor: 4.129

6.  Polygenic risk score for predicting weight loss after bariatric surgery.

Authors:  Juan de Toro-Martín; Frédéric Guénard; André Tchernof; Louis Pérusse; Simon Marceau; Marie-Claude Vohl
Journal:  JCI Insight       Date:  2018-09-06

7.  Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study.

Authors:  Catherine Rousseau; Sonia Jean; Philippe Gamache; Stéfane Lebel; Fabrice Mac-Way; Laurent Biertho; Laëtitia Michou; Claudia Gagnon
Journal:  BMJ       Date:  2016-07-27

8.  The Mid-Term Effects of Transit Bipartition with Sleeve Gastrectomy on Glycemic Control, Weight Loss, and Nutritional Status in Patients with Type 2 Diabetes Mellitus: a Retrospective Analysis of a 3-Year Follow-up.

Authors:  Akin Calisir; Ilhan Ece; Huseyin Yilmaz; Husnu Alptekin; Fahrettin Acar; Serdar Yormaz; Bayram Colak; Mustafa Sahin
Journal:  Obes Surg       Date:  2021-06-30       Impact factor: 3.479

9.  SADI-S WITH RIGHT GASTRIC ARTERY LIGATION: TECHNICAL SYSTEMATIZATION AND EARLY RESULTS.

Authors:  Jordi Pujol Gebelli; Amador Garcia Ruiz de Gordejuela; Almino Cardoso Ramos; Mario Nora; Ana Marta Pereira; Josemberg Marins Campos; Manoela Galvão Ramos; Eduardo Lemos de Souza Bastos; João Batista Marchesini
Journal:  Arq Bras Cir Dig       Date:  2016

10.  Prospective multicentre randomised trial comparing the efficacy and safety of single-anastomosis duodeno-ileal bypass with sleeve gastrectomy (SADI-S) versus Roux-en-Y gastric bypass (RYGB): SADISLEEVE study protocol.

Authors:  Maud Robert; Tigran Poghosyan; Dominique Delaunay; Elise Pelascini; Sylvain Iceta; Adrien Sterkers; Charles Barsamian; Litavan Khamphommala; Sylvie Bin Dorel; Delphine Maucort-Boulch; Sebastien Czernichow; Emmanuel Disse
Journal:  BMJ Open       Date:  2020-09-01       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.